Lundbeck
HLUN-B.CO
#2771
Rank
HK$45.03 B
Marketcap
HK$45.39
Share price
0.92%
Change (1 day)
3.00%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): HK$4.78

According to Lundbeck's latest financial reports the company's current EPS (TTM) is HK$4.80. an increase over its 2024 EPS that were of HK$3.46.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025HK$3.9714.5%
2024HK$3.4629.29%
2023HK$2.6823.09%
2022HK$2.1837.26%
2021HK$1.59-84.61%
2020HK$10.30-24.61%
2019HK$13.67-42.06%
2018HK$23.5940.7%
2017HK$16.77146.26%
2016HK$6.81-120.48%
2015-HK$33.243231.32%
2014-HK$1.00-115.78%
2013HK$6.32-23.36%
2012HK$8.25-48.01%
2011HK$15.87-9.68%
2010HK$17.5713.72%
2009HK$15.4524.32%
2008HK$12.43-6.05%
2007HK$13.2381.77%
2006HK$7.28-16.76%
2005HK$8.74-17.58%
2004HK$10.61